about
Distribution of brevetoxin (PbTx-3) in mouse plasma: association with high-density lipoproteins.Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeuticsSynthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albuminConformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutantsCharacterization of the Effect of Drug-Drug Interaction on Protein Binding in Concurrent Administration of Sulfamethoxazol and Diclofenac Sodium Using Bovine Serum AlbuminInfluence of galloyl moiety in interaction of epicatechin with bovine serum albumin: a spectroscopic and thermodynamic characterizationModeling Fatty Acid Transfer from Artery to CardiomyocyteA Comprehensive Spectroscopic and Computational Investigation to Probe the Interaction of Antineoplastic Drug Nordihydroguaiaretic Acid with Serum AlbuminsBinding of Sulpiride to Seric Albumins.Targeted non-covalent self-assembled nanoparticles based on human serum albumin.Albumin interacts specifically with a 60-kDa microvascular endothelial glycoproteinEffect of common buffers and heterocyclic ligands on the binding of Cu(II) at the multimetal binding site in human serum albuminDetermination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction.Interaction of the anticancer plant alkaloid sanguinarine with bovine serum albumin.Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding.Deuterium off-resonance rotating frame spin-lattice relaxation of macromolecular bound ligands.Unraveling the mysteries of serum albumin-more than just a serum protein.Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease.Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coliMultipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybridsFree fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.Plasma binding of thiopentone in late pregnancyDeciphering structural intermediates and genotoxic fibrillar aggregates of albumins: a molecular mechanism underlying for degenerative diseases.Investigation of the interaction of naringin palmitate with bovine serum albumin: spectroscopic analysis and molecular docking.Organization versus activation: the role of endocrine-disrupting contaminants (EDCs) during embryonic development in wildlife.Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albuminRenal type a intercalated cells contain albumin in organelles with aldosterone-regulated abundance.Interaction of avelox with bovine serum albumin and effect of the coexistent drugs on the reaction.Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells.A Spectroscopic Approach to Investigate the Molecular Interactions between the Newly Approved Irreversible ErbB blocker "Afatinib" and Bovine Serum Albumin.Functional chromatographic technique for natural product isolationHuman Serum Albumin (HSA) Suppresses the Effects of Glycerol Monolaurate (GML) on Human T Cell Activation and Function.cDNA and protein sequence of polymorphic macaque albumins that differ in bilirubin binding.High-throughput analysis of drug dissociation from serum proteins using affinity silica monolithsPhysiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography.Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC).Studies of verapamil binding to human serum albumin by high-performance affinity chromatography.Stereoselective binding of chiral drugs to plasma proteinsStudies of imipramine binding to human serum albumin by high-performance affinity chromatography
P2860
Q24810747-58C59A12-448D-4C57-B026-7839D61E0B19Q27675422-2A68D04B-A1B5-4662-AA27-BA5BBEF8943EQ27681441-E1C76096-0D7C-441B-9311-7D7D7E3C12D5Q28367254-D7445522-166D-4CFC-9F0E-0748E9FA3594Q28468550-E9092186-3F16-40F4-85F1-AAE275587262Q28482398-0BD0B8CB-106F-4FC6-9985-63900EE2F98BQ28551521-7BB41174-EA77-4B74-B9C8-845129B849F8Q28552462-8D2F316C-8E9C-4850-BABC-FCBEE33A0553Q30383282-0F032727-448A-4C97-A7FA-528B824A0567Q30653913-468024C9-8BFF-433D-9266-806F715EB176Q33647703-0EB36036-308F-4B0D-8067-2304FC9EA44AQ33831050-8C6F5041-DB21-4E2B-ABE0-BDFDB0193C59Q33847684-B08E31C6-CE3B-40D7-BCEF-B4D36CB2D3B4Q33873746-37CC3EBB-9856-4200-9165-9FB93ABE29E6Q33886355-5C1D098D-36C6-47D0-AE4C-90C270F5EC71Q34017441-25F999CF-F718-4C03-983E-090AFB89ECC3Q34030577-60C0079B-5218-4E7A-82FB-1D8439E9A334Q34155271-AFECE9D0-317C-4D2B-8692-D2AAC59EBA1CQ34245636-FE6146DC-BE65-40FF-82FE-16FE3073D2F1Q34394212-4DBDC700-740E-4E4E-86FB-C3A6716207D1Q34501763-DCB4B7F1-BC5D-4303-BF0D-FD32B7A1415BQ34512530-C9C787AC-82FD-4DDB-A50A-00800CBCD786Q34559100-5DCCD5BB-0434-40FE-A1F7-6FB5B8DB6E20Q34634657-68FF210B-5637-4934-AAC5-E8321C757C39Q34831794-4EF5BFD6-3907-49B5-8052-15E9896DD9BDQ35581476-B3138CC7-53AD-47C8-84F0-7412EC81BC60Q35601602-41497F78-B978-4D29-8186-EAF41FA67D13Q35810663-CE3235A8-DDE2-4C42-86AF-E43F90E31FDCQ35833012-C76A1A01-7B1F-4E20-B883-F0233A014A7EQ35889852-DFD97307-16ED-4599-B36D-1B6FAC0F12C1Q36078230-4CC91B99-2CA7-4320-8871-3FB0D27A03C1Q36169347-FCE9DE2E-9460-4603-8BF8-C122CF4F1A3DQ36173648-64600B7C-9576-44B6-BE1F-DD0AF4644E08Q36207575-417B0EC1-7044-4CE4-BC9A-56967DF2993DQ36807461-493ED155-DE5D-43EB-AFBE-C3BAAA255F95Q36859375-2DE9D5BD-3535-4A65-B768-FE1E4237C554Q36914806-2529E177-5CF2-432D-A856-B21F3072D4B6Q37004460-83671D2E-158D-4EE1-A319-2A5A1C4BA067Q37069257-CCC67DD1-F1CA-4F32-AE8D-30E834239F42Q37153456-BB0E79D1-F266-4597-A16C-8B7D3E285F95
P2860
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Molecular aspects of ligand binding to serum albumin.
@en
type
label
Molecular aspects of ligand binding to serum albumin.
@en
prefLabel
Molecular aspects of ligand binding to serum albumin.
@en
P1476
Molecular aspects of ligand binding to serum albumin
@en
P2093
Kragh-Hansen U
P577
1981-03-01T00:00:00Z